يعرض 1 - 10 نتائج من 7,133 نتيجة بحث عن '"PARP Inhibitor"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Targeted DNA damage repair: old mechanisms and new opportunities in clear cell renal cell carcinoma

    المؤلفون: Lv, Jiahua, Gong, Pengcheng, Jia, Gongwei, Li, WenAff1, IDs42764024001384_cor4

    المصدر: Genome Instability & Disease. :1-13

    Find this article in full text from Springer Verlag.
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer

    المؤلفون: Tai, YifanAff1, Aff8, Chow, Angela, Han, SeoyoungAff1, Aff9, Coker, Courtney, Ma, Wanchao, Gu, Yifan, Estrada Navarro, Valeria, Kandpal, Manoj, Hibshoosh, Hanina, Kalinsky, Kevin, Manova-Todorova, KatiaAff6, Aff10, Safonov, Anton, Walsh, Elaine MAff6, Aff11, Robson, Mark, Norton, Larry, Baer, RichardAff1, Aff4, Merghoub, Taha, Biswas, Anup KAff1, Aff4, IDs44321024000942_cor18, Acharyya, SwarnaliAff1, Aff4, Aff7, IDs44321024000942_cor19

    المصدر: EMBO Molecular Medicine. 16(8):1957-1980

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Comparative effectiveness of first-line systemic treatments for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

    المؤلفون: Ai, Jiahuan, Jian, Liuying, Wen, Xiaoqin, Huo, Xiaotong, Yang, Xuanyi, Jiang, JieAff1, IDs12094024035064_cor6, Zhang, TiantianAff1, Aff2, IDs12094024035064_cor7

    المصدر: Clinical and Translational Oncology. :1-13

    Find this article in full text from Springer Verlag. Full Text Finder
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    A case of hereditary breast and ovarian cancer syndrome of initially presented as cancer of unknown primary with lymph node metastases unveiled by genetic analysis

    المؤلفون: Yamada, Juri, Fukuda, Koji, Sugawara, Tae, Makino, Kenichi, Shimazu, Kazuhiro, Yoshida, Taichi, Taguchi, Daiki, Shinozaki, Hanae, Terada, Yukihiro, Nanjo, Hiroshi, Shibata, HiroyukiAff1, IDs13691023006524_cor11

    المصدر: International Cancer Conference Journal. 13(2):139-143

    Find this article in full text from Springer Verlag. Full Text Finder
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer

    المؤلفون: Yifan Tai, Angela Chow, Seoyoung Han, Courtney Coker, Wanchao Ma, Yifan Gu, Valeria Estrada Navarro, Manoj Kandpal, Hanina Hibshoosh, Kevin Kalinsky, Katia Manova-Todorova, Anton Safonov, Elaine M Walsh, Mark Robson, Larry Norton, Richard Baer, Taha Merghoub, Anup K Biswas, Swarnali Acharyya

    المصدر: EMBO Molecular Medicine, Vol 16, Iss 8, Pp 1957-1980 (2024)

    مصطلحات موضوعية: FLT1, VEGFR1, Breast Cancer, PARP-Inhibitor-Resistance, Medicine (General), R5-920, Genetics, QH426-470

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1757-4684

    URL الوصول: https://doaj.org/article/2b7acab7d8864163a88c5615d51c25ce

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial

    المؤلفون: Belotte, JimmyAff1, IDs13063024081425_cor1, Felicetti, Brunella, Baines, Amanda J., YoussefAgha, Ahmed, Rojas-Espaillat, Luis, Ortiz, Ana Godoy, Provencher, Diane, Vázquez, Raúl Márquez, Cortijo, Lucia González, Zeng, Xing

    المصدر: Trials. 25(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    A nano-cocktail of the PARP inhibitor talazoparib and CDK inhibitor dinaciclib for the treatment of triple negative breast cancer

    المؤلفون: Baldwin, Paige, Yang, Shicheng, Orriols, Adrienne, Wang, Sherrie, Brown, NeedaAff4, Aff5, Sridhar, SrinivasAff1, Aff2, Aff4, Aff5, IDs12645023002404_cor6

    المصدر: Cancer Nanotechnology: Basic,Translational and Clinical Research. 15(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

    المؤلفون: Sorrin, Aaron, Dasgupta, Anika, McNaughton, Kathryn, Arnau Del Valle, Carla, Zhou, Keri, Liu, Cindy, Roque, Dana M.Aff2, Aff3, Huang, Huang ChiaoAff1, Aff3, IDs13578024011976_cor8

    المصدر: Cell & Bioscience. 14(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    ER-positive and BRCA2-mutated breast cancer: a literature review

    المؤلفون: Li, Pu-ChunAff1, Aff2, Zhu, Yi-FanAff1, Aff2, Cao, Wen-MingAff2, IDs40001023016181_cor3, Li, BeiAff3, IDs40001023016181_cor4

    المصدر: European Journal of Medical Research. 29(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response

    المؤلفون: Pan, JiajiaAff1, Aff2, Wang, YunguiAff1, Aff2, Huang, Shujuan, Mao, ShihuiAff1, Aff2, Ling, QingAff1, Aff2, Li, ChenyingAff1, Aff2, Li, FenglinAff1, Aff2, Yu, Mengxia, Huang, XinAff1, Aff2, Huang, JiansongAff1, Aff2, Lv, YunfeiAff1, Aff2, Li, XiaAff1, Aff2, Ye, WenleAff1, Aff2, Wang, HuafengAff1, Aff2, Wang, JinghanAff1, Aff2, Aff5, IDs00109023024091_cor15, Jin, JieAff1, Aff2, Aff5, IDs00109023024091_cor16

    المصدر: Journal of Molecular Medicine. 102(3):415-433

    Find this article in full text from Springer Verlag. Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء